Datasets:

Suchinthana
/

support2-1

Dataset card Viewer Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
9,001	82.21497	1	male	1	26	26	COPD	COPD/CHF/Cirrhosis	3	null	null	0	54,639	38,227.9688	41,906.5	33	white	42	57	0.20697	0.063995	1	0	0	no	0.55	0.55	dnr after sadm	18	73	16.199219	120	14	38.19531	198.15625	1.399902	1.799805	0.899902	132	7.40918	183	36	1,610	null	null	<2 mo. follow-up	3.554199
9,002	75.60297	0	female	0	16	472	COPD	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	17,139	10,977.4531	11,774.9531	13.333328	white	26.699219	18	0.695923	0.531982	1	0	0	no	0.8	0.7	no dnr	16	117	8.099609	122	36	38.59375	338.0625	3.399902	0.599976	0.699951	128	7.489258	274	17	1,200	null	2	no(M2 and SIP pres)	2
9,003	81.72198	1	male	0	4	437	COPD	COPD/CHF/Cirrhosis	3	8	under $11k	0	3,043	2,024.9912	2,515.10938	16	white	15	19	0.80188	0.680908	1	0	0	yes	0.99	0.9	dnr after sadm	2	113	8.699219	98	42	38.09375	124	3	0.899902	0.899902	141	7.459961	286	33	1,910	null	null	no(M2 and SIP pres)	2.884766
9,004	57.396	1	female	0	19	69	Colon Cancer	Cancer	2	10	under $11k	0	13,334	8,906.5859	8,470.92969	6.666664	other	23.796875	17	0.724976	0.450989	1	1	0	metastatic	0.6	0.2	dnr after sadm	1	78	18.199219	140	22	37.79688	null	3.399902	0.799927	1	128	null	133	14	2,900	0	4	SIP>=30	4
9,005	60.64099	0	male	0	4	468	COPD	COPD/CHF/Cirrhosis	1	10	null	0	2,783	1,856.5303	2,369.85938	6	white	19	16	0.890991	0.817993	1	0	0	no	0.85	0.8	no dnr	4	125	13.298828	100	24	38.79688	null	2	0.199982	2.599609	149	null	162	54	1,350	0	null	no(M2 and SIP pres)	0.494751
9,006	73.00195	0	female	0	19	469	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$11-$25k	0	24,180	15,589.9375	18,584.8281	16.333328	white	25.5	36	0.698975	0.608887	1	0	0	yes	null	null	dnr after sadm	14	70	8.199219	172	24	36.09375	153.03125	2.699707	1	1	144	7.399414	113	46	4,225	1	1	adl>=4 (>=5 if sur)	1
9,007	40.19699	0	female	0	29	466	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	0	63,906	42,971.0625	46,177	26	white	24.199219	44	0.8479	0.795898	5	0	0	no	null	null	no dnr	29	119	16.597656	118	32	36.19531	308	3.299805	0.399963	0.699951	138	7.459961	310	18	2,025	null	null	no(M2 and SIP pres)	1.858154
9,008	75.19196	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	44	31,223	20,360.9844	19,235.6875	52	white	28.597656	37	0.491943	0.373962	1	1	0	no	0.1	0.1	dnr after sadm	7	57	11.199219	66	14	38.59375	262.5	2.699707	0.5	0.799927	139	7.459961	84	18	580	null	2	<2 mo. follow-up	2
9,009	42.61499	0	male	0	18	461	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	0	48,707	32,075.2656	32,547.75	25.666656	white	18.199219	29	0.916992	0.886963	1	0	0	no	0.6	0.6	no dnr	18	117	6.599609	67	24	36.39844	308.6875	4.099609	1	1.899902	138	7.469727	216	31	1,550	null	0	SIP>=30	0
9,010	64.29297	1	female	0	11	84	COPD	COPD/CHF/Cirrhosis	4	null	null	37	16,955	11,483.3438	13,552.8594	23.5	white	26.5	37	0.592896	0.401978	1	0	0	yes	0.75	0.75	no dnr	11	106	6.5	93	16	36.09375	null	4.399414	0.399963	1.199951	139	null	108	16	2,475	null	null	null	4.527344
9,011	63.866	1	male	0	4	21	Lung Cancer	Cancer	2	12	$25-$50k	0	2,016	1,293.1191	1,384.15918	5	white	18.398438	21	0.681885	0.386963	1	1	0	metastatic	0.2	0.5	no dnr	4	72	null	106	10	35.69531	null	null	null	1.399902	136	null	152	27	2,370	1	5	<2 mo. follow-up	5
9,012	40.241	1	female	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	2	13	$25-$50k	0	59,750	43,047.4375	37,539.2812	51	white	41.195313	66	0.462952	0.343994	29	1	0	no	null	null	dnr after sadm	6	84	8.398438	76	20	36.39844	null	null	null	1.199951	134	null	159	20	null	null	null	<2 mo. follow-up	2.271484
9,013	70.80896	0	male	0	24	460	COPD	COPD/CHF/Cirrhosis	3	21	$11-$25k	0	28,045	null	null	19.666656	white	21.398438	27	0.81897	0.705933	1	0	0	no	0.8	0.6	no dnr	24	120	8.199219	83	24	35.79688	247.59375	null	0.699951	0.799927	138	7.40918	84	13	null	0	0	no(M2 and SIP pres)	0
9,014	74.52197	1	female	0	3	309	CHF	COPD/CHF/Cirrhosis	5	8	$11-$25k	0	2,172	1,436.1357	1,715.0293	4	white	38.695313	40	0.343994	0.155975	1	1	0	yes	0.7	0.6	no dnr	3	67	23.398438	98	24	35.79688	195.21875	2.699707	0.299988	0.599976	131	7.419922	141	14	null	null	null	no(M2 and SIP pres)	2.848633
9,015	65.71399	0	male	0	5	454	COPD	COPD/CHF/Cirrhosis	1	11	$25-$50k	0	3,842	2,439.6562	2,197.91992	10	white	9	20	0.940918	0.898926	1	0	0	no	0.8	0.8	no dnr	5	81	13.398438	73	24	36.09375	204	null	null	1.199951	142	7.349609	191	33	3,175	1	0	no(M2 and SIP pres)	0
9,016	88.46497	0	female	0	8	453	MOSF w/Malig	ARF/MOSF	0	8	null	9	19,050	12,381.9688	11,637.8594	10	white	18.398438	21	0.691895	0.599976	6	0	0	yes	null	null	no dnr	8	63	7.699219	64	16	36.29688	null	3.399902	0.399963	1.299805	134	null	101	24	950	5	6	no(M2 and SIP pres)	6
9,017	68.41095	1	male	0	22	46	Coma	Coma	1	14	$25-$50k	26	50,312	33,776.4688	35,563.0312	17.666656	white	16.398438	22	0.633911	0.571899	20	0	0	no	0.5	0.3	dnr after sadm	2	63	6.099609	106	10	39	420	2.899902	1.299805	0.599976	131	7.439453	141	12	2,500	0	0	<2 mo. follow-up	0
9,018	75.16998	0	female	0	13	451	COPD	COPD/CHF/Cirrhosis	3	8	null	26	13,763	9,029.9922	8,189.79688	15	white	23.796875	57	0.665894	0.491943	1	0	0	no	0.75	0.75	no dnr	13	119	13.199219	104	28	35.59375	264	3.599609	0.799927	1.099854	131	7.269531	316	21	null	null	0	no(M2 and SIP pres)	0
9,019	66.96198	1	female	1	59	59	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	100	191,281	null	null	42.75	white	29	65	0.128998	0.057999	39	0	0	no	0.2	0	dnr after sadm	29	52	10.798828	72	34	38.59375	153.3125	1.599854	4.5	1	140	7.479492	131	24	4,105	null	0	<2 mo. follow-up	0
9,020	78.10498	0	male	0	95	447	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	9	177,145	120,634.875	129,924.25	28.25	white	25.699219	50	0.611938	0.505981	13	0	0	no	null	null	no dnr	95	72	14.199219	68	8	37.89844	190	4.399414	0.299988	1.099854	137	7.389648	181	15	2,915	null	0	adl>=4 (>=5 if sur)	0
9,021	74.90198	0	male	0	8	446	COPD	COPD/CHF/Cirrhosis	1	8	under $11k	0	5,133	3,393.2227	3,857.24805	7	white	15.199219	21	0.870972	0.785889	1	0	0	no	null	null	dnr after sadm	1	98	11.5	69	22	36.19531	null	null	1.099854	1.099854	139	null	116	13	null	0	0	no(M2 and SIP pres)	0
9,022	67.40295	1	female	0	4	159	COPD	COPD/CHF/Cirrhosis	4	8	under $11k	0	2,456	1,675.9453	1,609.0498	2	white	16.296875	15	0.889893	0.814941	1	0	0	no	0.8	0.4	dnr after sadm	3	67	7.599609	57	20	35.69531	null	4.699219	1.399902	1.799805	139	null	88	35	2,000	2	null	no(M2 and SIP pres)	1.838867
9,023	71.54297	0	male	0	7	445	CHF	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	5,544	3,609.9824	3,011.10938	3.5	white	25.398438	36	0.765991	0.628906	1	0	0	no	0.7	0.6	no dnr	7	76	10	121	24	36.19531	540	null	null	1.399902	133	7.509766	110	24	1,250	0	0	no(M2 and SIP pres)	0
9,024	48.89798	1	female	1	7	7	Coma	Coma	3	null	null	100	22,480	16,014.5625	14,999.1797	10.5	white	25.398438	49	0.246979	0.181	6	0	0	no	0.35	0.35	no dnr	7	76	9.798828	60	14	36.39844	null	null	null	4.399414	132	null	143	86	3,550	null	null	<2 mo. follow-up	3.05127
9,025	58.26099	0	female	0	46	442	Coma	Coma	4	9	under $11k	44	47,880	30,861.125	47,698.1875	17	white	23.796875	27	0.480957	0.407959	1	1	0	yes	0.5	0.4	dnr after sadm	1	65	8.898438	63	27	38.09375	320	2.699707	1.5	1.399902	146	7.399414	177	30	3,750	null	0	adl>=4 (>=5 if sur)	0
9,026	64.25494	0	male	0	4	442	COPD	COPD/CHF/Cirrhosis	4	9	under $11k	0	2,845	1,856.4043	1,873.64941	8	white	15.199219	15	0.884888	0.80896	1	0	0	yes	0.9	0.9	no dnr	4	64	13.599609	100	28	36.19531	105	3	4.899414	0.799927	131	7.479492	155	19	1,400	null	null	null	2.475586
9,027	53.38797	1	male	0	20	184	MOSF w/Malig	ARF/MOSF	1	12	null	0	44,781	81,412.1875	79,421.375	24.333328	white	26.597656	55	0.550903	0.437988	24	0	0	yes	0.6	0.5	no dnr	20	108	15	80	10	39.5	401	4.099609	0.899902	1.799805	140	7.479492	161	15	2,250	0	0	no(M2 and SIP pres)	0
9,028	54.48898	0	male	0	19	440	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	9	55,248	37,118.6562	36,838.3125	24.666656	white	25.296875	35	0.754883	0.67688	7	0	0	no	0.8	0.8	no dnr	19	108	11	58	10	36.29688	156	3.799805	0.799927	1.199951	143	7.5	182	32	825	null	0	no(M2 and SIP pres)	0
9,029	59.96698	1	male	1	15	15	ARF/MOSF w/Sepsis	ARF/MOSF	5	5	$11-$25k	100	27,965	20,384.6875	19,829.9219	34.333313	white	46.398438	85	0.007	0.001	1	1	0	no	0.25	0.5	no dnr	15	107	5.899414	72	7	36.09375	158	3.199707	0.599976	1.099854	141	7.489258	133	33	700	null	6	<2 mo. follow-up	6
9,030	58.64999	1	male	0	17	394	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	9	19,976	13,563.8828	12,909.9297	17.333328	white	25	45	0.791992	0.723999	1	0	0	no	0.5	0.4	no dnr	17	117	1	76	20	36.59375	null	4.199219	0.899902	0.899902	139	null	169	21	2,150	null	null	null	2.914063
9,031	57.50897	0	female	0	5	436	COPD	COPD/CHF/Cirrhosis	2	10	null	0	3,509	2,254.9258	2,080.41992	5	white	14.898438	10	0.928955	0.878906	1	0	0	no	0.9	0.8	no dnr	5	77	19.796875	104	20	36.09375	null	2.799805	1.099854	1.199951	120	null	155	28	null	1	null	no(M2 and SIP pres)	1.166748
9,032	41.66998	0	male	0	47	436	COPD	COPD/CHF/Cirrhosis	7	12	under $11k	0	91,054	null	null	31.75	white	49.898438	97	0.399963	0.201996	6	1	0	no	0.3	0.3	no dnr	47	55	29.097656	50	14	36.69531	163.25	3.799805	2.399902	2.899902	132	7.429688	202	68	2,350	null	null	adl>=4 (>=5 if sur)	3.859863
9,033	75.737	0	female	0	6	436	COPD	COPD/CHF/Cirrhosis	2	null	null	0	4,229	2,747.5625	2,469.00977	8	white	15.298828	23	0.865967	0.777954	1	0	0	no	null	null	dnr after sadm	1	79	8.099609	60	20	35.69531	null	4.5	1.099854	1.299805	136	null	104	28	2,900	null	null	no(M2 and SIP pres)	2.251465
9,034	73.98999	0	male	0	6	436	CHF	COPD/CHF/Cirrhosis	4	12	$11-$25k	0	4,473	2,867.5469	2,806.33984	9	white	18.796875	24	0.810913	0.69397	1	0	0	yes	null	null	dnr after sadm	1	68	10.798828	78	28	36	456.625	null	0.599976	1.199951	128	7.459961	124	23	1,380	1	1	no(M2 and SIP pres)	1
9,035	60.68997	0	male	0	9	436	CHF	COPD/CHF/Cirrhosis	3	9	$11-$25k	0	10,136	6,580.168	5,716.26953	7	white	16.597656	15	0.876953	0.795898	1	0	0	yes	0.95	0.8	no dnr	9	99	6.299805	74	20	36.09375	309.5	null	null	1.099854	143	7.449219	154	16	3,750	null	null	no(M2 and SIP pres)	2.611328
9,036	61.81799	1	female	0	17	77	ARF/MOSF w/Sepsis	ARF/MOSF	2	13	$25-$50k	0	52,105	74,461.5625	80,589.5625	39.333313	white	22.597656	40	0.770996	0.696899	3	0	0	yes	0.25	0.25	dnr after sadm	1	113	17.597656	114	28	36.09375	260	3.199707	0.299988	0.699951	136	7.399414	210	12	625	null	1	SIP>=30	1
9,037	77.27594	1	male	0	7	109	CHF	COPD/CHF/Cirrhosis	6	10	>$50k	0	5,305	3,511.0664	3,154.50977	4	white	29.796875	40	0.574951	0.381958	1	0	0	yes	null	null	no dnr	7	79	13.5	68	24	35.59375	276.1875	3.399902	0.5	1.699951	137	7.319336	255	45	1,250	1	1	no(M2 and SIP pres)	1
9,038	81.36896	1	female	1	27	27	MOSF w/Malig	ARF/MOSF	1	12	$11-$25k	0	49,066	34,163.25	34,912.1562	22.25	white	30.097656	48	0.524902	0.408997	1	0	0	yes	0.8	0.6	dnr after sadm	26	105	1.699951	128	35	38.19531	80	null	0.5	1.099854	127	7.519531	175	22	3,850	null	1	<2 mo. follow-up	1
9,039	68.39398	1	female	0	15	28	Lung Cancer	Cancer	3	null	null	0	15,760	10,211.2812	8,562.27344	7.666664	white	21.199219	20	0.605957	0.28894	1	0	0	metastatic	0.4	0.3	no dnr	15	115	9.798828	74	20	36.09375	null	3.799805	1.799805	1.299805	137	null	111	27	1,900	1	2	<2 mo. follow-up	2
9,040	70.67499	0	female	0	7	430	COPD	COPD/CHF/Cirrhosis	3	14	null	0	6,195	3,941.9727	3,448.26953	6	white	16.199219	33	0.87793	0.796997	1	1	0	no	0.5	0.3	dnr before sadm	-1	71	13.099609	54	20	36.89844	null	4.699219	0.5	1.199951	134	null	194	16	2,875	4	null	no(M2 and SIP pres)	3.183106
9,041	68.10394	0	female	0	20	430	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	61,528	41,360.8438	43,886.8438	21.666656	white	27.296875	36	0.688965	0.595947	6	0	0	no	0.5	0.4	no dnr	20	87	1.799805	64	22	36.29688	null	4	0.799927	1.099854	134	null	118	9	3,100	null	0	null	0
9,042	63.59799	1	female	0	5	7	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	0	38,249	23,373.0781	24,709.9062	23	white	19.5	50	0.81189	0.75	28	0	0	no	0.1	0	dnr after sadm	1	80	12.099609	74	22	36.39844	null	null	null	0.799927	135	null	205	12	2,225	null	2	<2 mo. follow-up	2
9,043	80.12897	1	male	0	10	55	Cirrhosis	COPD/CHF/Cirrhosis	1	8	null	9	6,034	4,013.293	3,842.2793	7	white	18.5	28	0.648926	0.470947	1	0	0	no	0.5	0.3	dnr after sadm	9	63	6.5	122	40	36	128.5625	null	1.099854	1.099854	142	7.379883	126	45	null	null	5	<2 mo. follow-up	5
9,044	72.76898	1	male	1	6	6	Coma	Coma	3	11	null	37	14,014	9,511.0781	9,680.61719	35	white	33.296875	66	0.116989	0.071991	1	0	0	yes	null	null	no dnr	6	64	1.699951	69	24	36.5	366.625	4.199219	0.899902	1.199951	134	7.439453	127	11	1,925	null	null	<2 mo. follow-up	2.409668
9,045	58.26099	0	male	0	17	423	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	$25-$50k	0	58,584	39,209.1562	42,428.875	33.333313	white	31.296875	58	0.667969	0.571899	4	0	0	no	0.8	0.512	no dnr	17	69	16.796875	117	26	36.89844	400	null	null	5.099609	134	7.459961	135	80	220	null	0	no(M2 and SIP pres)	0
9,046	76.53894	1	male	0	5	129	Lung Cancer	Cancer	1	8	null	0	4,560	2,875.1504	2,534.88867	9	white	10.5	11	0.796997	0.56897	1	0	0	metastatic	0.7	0.3	no dnr	5	44	0.299988	170	24	38.29688	183.65625	3	0.899902	5	137	7.369141	237	96	5	null	null	no(M2 and SIP pres)	1.930908
9,047	91.30695	0	female	0	3	421	CHF	COPD/CHF/Cirrhosis	6	9	null	0	1,573	1,085.8164	1,157.38965	null	white	18.699219	20	0.736938	0.587891	1	0	1	yes	0.5	0.3	dnr after sadm	1	110	10.599609	62	24	36	283.3125	3	0.899902	0.899902	138	7.449219	110	11	2,600	null	null	null	5.493164
9,048	46.836	0	male	0	70	423	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	under $11k	44	59,768	64,931.875	65,340.1562	20	white	20	13	0.814941	0.75293	1	0	0	no	0.1	0.1	no dnr	70	158	27.296875	118	29	36.39844	220	null	null	1	142	7.589844	171	16	1,800	null	0	adl>=4 (>=5 if sur)	0
9,049	77.69995	0	male	0	9	421	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	null	0	9,447	6,500.4805	7,083.86719	9.5	white	16.898438	20	0.856934	0.807983	1	0	0	no	0.9	0.9	no dnr	9	77	6.199219	140	28	35.29688	338.0625	3.899902	0.5	3.599609	137	7.339844	88	49	800	0	0	no(M2 and SIP pres)	0
9,050	61.09497	1	male	0	13	52	Colon Cancer	Cancer	2	12	null	0	15,908	10,149.2031	10,831.7188	18.5	white	18.097656	13	0.809937	0.592896	1	0	0	metastatic	0.5	0.25	dnr after sadm	1	104	null	118	18	36.09375	null	null	null	0.799927	133	null	128	18	3,350	0	0	<2 mo. follow-up	0
9,051	30.683	1	male	1	10	10	Coma	Coma	1	null	null	100	20,055	14,092.5156	16,231.6641	33	other	27.296875	38	0.459961	0.385986	1	0	0	no	null	null	dnr after sadm	7	101	17.398438	77	12	36.39844	177.125	null	null	0.799927	139	7.369141	132	15	1,975	null	null	<2 mo. follow-up	3.193359
9,052	72.24896	0	male	0	6	420	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	13,811	10,387.7812	10,449.4062	29	white	21.097656	28	0.822998	0.762939	1	0	0	no	0.75	0.75	no dnr	6	78	7.299805	59	24	36.29688	323.75	null	0.599976	2	137	7.389648	203	51	null	null	null	null	1.744873
9,053	59.59998	0	male	0	23	417	COPD	COPD/CHF/Cirrhosis	0	12	null	0	35,184	23,657.5312	25,296.1719	28.666656	white	29.898438	48	0.763916	0.625	1	0	0	no	0.6	0.55	no dnr	23	63	null	112	24	36.09375	null	null	null	1.299805	136	null	104	16	2,225	null	0	adl>=4 (>=5 if sur)	0
9,054	45.35498	0	female	0	44	418	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	null	0	83,628	null	null	15.5	white	27	52	0.772949	0.699951	2	0	0	yes	0.8	0.7	no dnr	44	81	8.699219	53	24	35.09375	null	3.299805	0.5	1.699951	131	null	108	33	3,100	0	0	SIP>=30	0
9,055	76.25995	1	female	1	23	23	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	null	0	62,544	44,539.9062	38,243.4688	41.333313	white	28.5	55	0.681885	0.588989	1	1	0	no	0.49	0.49	dnr after sadm	13	120	17	76	32	36.59375	183.3125	null	null	2	141	7.40918	202	40	1,920	null	0	<2 mo. follow-up	0
9,056	74.05896	1	female	0	17	79	Lung Cancer	Cancer	1	11	$11-$25k	0	13,262	8,684.1641	9,621.92969	12	white	18.699219	14	0.649902	0.343994	1	0	0	metastatic	0.5	0.2	no dnr	17	56	17.796875	76	10	36	111.65625	2.199707	0.599976	1.399902	151	7.429688	76	39	2,625	5	7	adl>=4 (>=5 if sur)	7
9,057	56.60498	0	male	0	10	412	COPD	COPD/CHF/Cirrhosis	2	8	null	0	18,098	12,675.5469	14,040.2969	24.5	white	24.699219	38	0.851929	0.756958	1	0	0	no	0.9	0.9	no dnr	10	48	12.298828	137	9	38.19531	97.76562	null	null	0.599976	140	7.429688	256	10	1,100	null	1	no(M2 and SIP pres)	1
9,058	65.51697	1	female	0	15	80	CHF	COPD/CHF/Cirrhosis	5	10	null	0	16,334	11,352.4531	9,983.50781	10.333328	white	23	29	0.824951	0.715942	1	1	0	no	0.75	0.6	no dnr	15	74	12.298828	134	36	39.5	234.28125	null	null	0.699951	140	7.509766	224	21	2,285	null	null	adl>=4 (>=5 if sur)	3.375488
9,059	69.67297	0	male	0	11	411	CHF	COPD/CHF/Cirrhosis	3	17	>$50k	0	15,937	10,393.5	9,543.625	23	white	19.398438	34	0.853882	0.759888	1	1	0	no	0.8	0.8	dnr after sadm	2	66	12.599609	79	20	36.39844	null	3.699707	0.399963	1.199951	135	null	124	21	2,800	null	2	no(M2 and SIP pres)	2
9,060	36.73398	0	male	0	12	409	MOSF w/Malig	ARF/MOSF	2	13	$25-$50k	0	24,756	16,661.5625	15,449.0938	25.5	white	35.09375	48	0.419983	0.300964	3	0	0	yes	0.4	0.3	no dnr	12	71	9.599609	60	20	36.19531	247.59375	null	null	null	140	7.399414	null	null	1,650	null	0	no(M2 and SIP pres)	0
9,061	65.96594	0	female	0	9	408	COPD	COPD/CHF/Cirrhosis	0	12	null	0	8,106	5,174.0039	7,386.21875	7.5	white	19.5	24	0.865967	0.777954	1	0	0	no	0.7	0.5	no dnr	9	75	11.298828	74	20	35.5	460	null	null	1.199951	143	7.389648	154	21	1,050	0	2	no(M2 and SIP pres)	2
9,062	77.58197	1	female	0	5	6	MOSF w/Malig	ARF/MOSF	1	null	null	0	22,607	15,861.0156	16,418.1562	32	white	20	26	0.657959	0.55896	4	0	0	metastatic	null	null	no dnr	5	47	23.898438	102	24	38.19531	215.6875	2.099609	2	0.799927	130	7.399414	230	17	1,162	null	null	<2 mo. follow-up	2.355469
9,063	44.44397	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	$11-$25k	0	26,887	18,224.4375	23,413.7188	34.5	white	26.796875	40	0.813965	0.751953	3	0	0	no	0.3	0.3	no dnr	8	119	12.199219	79	16	36.29688	null	2.899902	0.5	0.599976	139	null	142	12	3,650	null	0	<2 mo. follow-up	0
9,064	65.96594	1	male	0	5	320	Cirrhosis	COPD/CHF/Cirrhosis	2	12	null	0	3,082	2,044.9668	2,643.20898	11	white	26.398438	43	0.622925	0.437988	1	1	0	no	0.8	0.4	no dnr	5	48	5.099609	79	16	36.29688	null	3.899902	0.5	1.399902	136	null	205	14	3,750	3	2	no(M2 and SIP pres)	2
9,065	36.81	1	female	1	25	25	MOSF w/Malig	ARF/MOSF	1	14	null	0	127,198	82,520.25	87,494.75	36	white	45.59375	78	0.045998	0.014	13	0	0	metastatic	0.75	0.7	no dnr	25	79	8.298828	104	24	36.19531	319	null	0.5	0.699951	131	7.399414	110	5	4,800	null	0	<2 mo. follow-up	0
9,066	79.61694	1	male	0	14	35	Lung Cancer	Cancer	1	12	null	0	8,930	5,929.5664	5,859.21875	9.333328	white	14.599609	6	0.720947	0.44397	1	0	0	metastatic	0.4	0.1	no dnr	14	64	8	112	24	38.69531	314.25	4.299805	0.599976	1.199951	139	7.519531	123	16	1,775	null	0	<2 mo. follow-up	0
9,067	69.36597	0	male	0	6	405	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$25-$50k	0	6,555	4,531.9766	4,346.07812	16	white	26.597656	38	0.750977	0.671997	1	0	0	no	0.95	0.9	no dnr	6	120	10.898438	110	32	35.5	163.25	2.5	0.299988	1.099854	149	7.449219	149	30	4,375	0	0	no(M2 and SIP pres)	0
9,068	50.41199	0	male	0	15	403	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	0	51,775	35,385.375	36,503.4062	29.333328	white	25.796875	33	0.794922	0.727905	5	0	0	no	0.9	0.9	no dnr	15	133	24.796875	120	10	39	126.14062	2.799805	1.399902	3.199707	150	7.329102	81	64	840	null	0	SIP>=30	0
9,069	75.13995	0	male	0	37	403	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	null	9	59,514	38,261.4688	40,055.5312	22.75	white	21.898438	41	0.763916	0.687988	2	0	0	no	null	null	no dnr	37	81	13.398438	64	16	36.29688	195.90625	null	0.699951	1.099854	138	6.829102	320	20	1,925	null	null	null	2.601074
9,070	53.21298	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	44	18,549	12,547.3359	17,883.6094	45	white	27.898438	35	0.644897	0.544922	1	1	0	no	0.25	0.2	dnr after sadm	1	59	19.199219	130	12	36.39844	131.09375	3	0.799927	2.199707	135	7.359375	123	60	3,105	null	0	<2 mo. follow-up	0
9,071	77.33295	1	female	0	3	20	Lung Cancer	Cancer	2	12	$11-$25k	0	1,212	805.0625	846.78955	3	white	15.199219	14	0.715942	0.435974	1	0	0	metastatic	0.4	0.2	dnr after sadm	1	67	7.799805	74	28	38.39844	154.28125	null	0.899902	1.099854	143	7.419922	165	18	1,025	0	0	<2 mo. follow-up	0
9,072	48.405	1	female	1	11	11	MOSF w/Malig	ARF/MOSF	1	13	null	44	76,273	49,159.5	51,156.3125	45	white	44.695313	91	0.004	0.001	7	0	0	metastatic	0.5	0.48	dnr after sadm	9	65	10.699219	74	24	36.19531	192	null	null	1	144	7.399414	104	22	2,600	null	0	<2 mo. follow-up	0
9,073	49.11697	0	male	0	6	394	COPD	COPD/CHF/Cirrhosis	2	8	under $11k	0	5,799	3,943.543	3,946.1582	12	white	15.599609	27	0.942993	0.902954	1	0	0	no	null	null	no dnr	6	109	3.5	71	24	36.19531	336	2.399902	8.199219	0.899902	137	7.259766	139	11	null	null	null	null	2.98584
9,074	70.36798	0	male	0	4	394	COPD	COPD/CHF/Cirrhosis	2	8	$11-$25k	0	4,504	3,093.8516	3,748.84961	11	white	20.398438	18	0.834961	0.72998	1	0	0	no	null	null	no dnr	4	67	6.899414	66	28	36.29688	238.09375	4.5	1.5	2	143	7.449219	143	53	1,175	null	null	no(M2 and SIP pres)	2.3125
9,075	66.146	1	male	1	12	12	MOSF w/Malig	ARF/MOSF	2	null	under $11k	37	53,671	37,465.8438	36,988	33.5	white	23.199219	50	0.430969	0.311951	40	0	0	yes	null	null	dnr after sadm	6	59	8.798828	128	40	36.29688	null	2.5	1.899902	1.399902	134	null	108	24	2,700	null	null	<2 mo. follow-up	2.387695
9,076	63.43298	1	male	0	3	143	Lung Cancer	Cancer	2	10	null	0	1,822	1,216.1992	1,412	null	white	13.099609	9	0.779907	0.540894	1	0	0	metastatic	null	null	no dnr	3	71	16.597656	48	16	36.19531	null	2.5	0.299988	0.799927	131	null	77	15	1,500	null	null	null	2.046875
9,077	59.53198	1	female	0	13	22	Coma	Coma	0	13	>$50k	89	22,471	18,157.375	19,222.3906	26	white	21.597656	14	0.385986	0.312988	1	0	0	no	null	null	dnr after sadm	7	59	14.798828	94	10	38.09375	282.5	null	null	1.699951	133	7.5	405	31	2,750	null	0	<2 mo. follow-up	0
9,078	62.84998	0	male	0	93	391	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	null	0	188,562	128,103.5	131,823.5	35.75	white	17.796875	8	0.882935	0.841919	1	1	0	no	null	null	dnr after sadm	55	65	19.296875	140	22	36.59375	195	null	null	2	132	7.449219	137	58	2,570	null	2	adl>=4 (>=5 if sur)	2
9,079	76.72797	1	male	0	4	242	Lung Cancer	Cancer	1	12	null	0	10,134	6,054.043	5,996.03906	10	white	6.299805	15	0.850952	0.670898	1	0	0	metastatic	0.99	0.75	no dnr	4	91	3.299805	67	16	36.09375	null	3.599609	0.5	0.899902	136	null	97	9	1,475	null	null	no(M2 and SIP pres)	1.775391
9,080	53.32498	1	male	0	5	308	Lung Cancer	Cancer	2	12	$25-$50k	0	5,467	3,386.6055	1,845.12988	11	white	11	18	0.827881	0.625977	1	1	0	metastatic	0.6	0.3	no dnr	5	71	8	135	20	36.39844	230.40625	null	1.299805	1.099854	137	7.30957	118	19	1,510	null	null	no(M2 and SIP pres)	1.976563
9,081	51.47998	0	male	0	40	386	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	33,830	22,221.5781	18,956.8906	10.25	white	35.296875	70	0.662964	0.564941	1	1	0	no	0.9	0.85	no dnr	40	60	0.199982	160	34	38.39844	null	2.799805	0.899902	1	141	null	169	26	null	null	2	null	2
9,082	54.05298	1	male	0	9	272	Lung Cancer	Cancer	1	12	$25-$50k	0	7,228	4,629.1406	4,348.85938	9.5	white	18.097656	18	0.710938	0.429993	1	0	0	metastatic	0.5	0.2	no dnr	9	125	12.699219	78	25	38.29688	256	1.899902	2	1.299805	144	7.479492	121	47	3,100	0	0	no(M2 and SIP pres)	0
9,083	75.40594	1	male	1	10	10	Coma	Coma	2	null	null	89	32,243	21,154.6875	22,736.2344	39	white	27.097656	50	0.050995	0.025997	1	1	0	yes	0.1	0.02	dnr after sadm	6	109	15.398438	110	30	36.19531	222.5	3.699707	0.799927	0.899902	140	7.239258	147	18	1,515	null	0	<2 mo. follow-up	0
9,084	85.66498	1	female	1	4	4	Coma	Coma	1	8	under $11k	100	3,906	2,507.3887	2,277.03906	19	white	17.699219	28	0.181976	0.123993	1	1	0	no	0.1	0	dnr after sadm	1	102	24.296875	70	20	35.89844	null	null	null	1.199951	137	null	158	11	null	null	1	<2 mo. follow-up	1
9,085	65.06195	1	female	0	16	376	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	null	0	19,709	13,702.2266	13,249.0234	19.333328	white	25.597656	44	0.783936	0.713989	1	1	0	no	null	null	no dnr	16	109	7.399414	63	16	35.39844	null	2.899902	1	1.299805	139	null	130	27	null	1	0	no(M2 and SIP pres)	0
9,086	18.41499	0	male	0	9	380	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	>$50k	0	22,047	13,396.9062	14,879.5469	23	white	19.699219	17	0.910889	0.878906	4	0	0	yes	0.98	0.96	no dnr	9	65	38.398438	104	30	36	152.5	null	1	1.299805	132	7.419922	243	25	1,225	null	0	null	0
9,087	70.48297	0	male	0	4	364	COPD	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	2,787	1,799.1553	1,919.35938	7	white	21.199219	26	0.780884	0.649902	1	0	0	yes	0.9	0.9	no dnr	4	93	15.5	69	32	36	280.9375	null	0.399963	1.199951	139	7.399414	144	32	950	null	null	no(M2 and SIP pres)	2.322266
9,088	75.50696	0	male	0	23	364	COPD	COPD/CHF/Cirrhosis	1	13	$11-$25k	41	45,129	30,240.5156	37,300.8438	34	white	22.398438	29	0.633911	0.450989	1	0	0	no	0.5	0.35	dnr after sadm	16	102	null	71	24	35.89844	null	null	null	null	140	null	null	null	null	null	0	no(M2 and SIP pres)	0
9,089	51.452	1	female	0	3	337	Lung Cancer	Cancer	1	12	$11-$25k	0	8,023	4,859.3516	3,317.91992	11	white	13.699219	12	0.793945	0.563965	1	0	0	metastatic	0.99	0.99	no dnr	3	118	9.599609	60	16	36.19531	null	3.599609	0.399963	2.599609	135	null	154	59	1,450	null	null	no(M2 and SIP pres)	1.922607
9,090	74.62	0	male	0	9	361	CHF	COPD/CHF/Cirrhosis	5	12	null	0	6,963	4,772.4609	5,048.37891	10	white	20.796875	25	0.777954	0.645996	1	1	0	yes	null	null	no dnr	9	66	8.398438	132	23	38.59375	215	2.099609	1.899902	0.799927	143	7.399414	280	38	2,650	0	0	null	0
9,091	64.51196	0	male	0	14	361	COPD	COPD/CHF/Cirrhosis	2	8	$11-$25k	0	23,105	16,030.1719	15,379.2188	18	white	32.398438	60	0.654907	0.477966	2	0	0	no	0.3	0.15	no dnr	14	49	19.5	116	34	36	208.5625	2.599609	0.399963	2.699707	136	7.289062	175	50	1,205	null	0	no(M2 and SIP pres)	0
9,092	79.17596	0	male	0	27	359	COPD	COPD/CHF/Cirrhosis	2	4	under $11k	9	20,070	13,088.1406	14,808.3359	7	white	22.097656	28	0.724976	0.570923	1	0	0	no	0.9	0.5	dnr after sadm	20	80	15.798828	107	32	35.69531	328	3	0.299988	0.699951	135	7.449219	149	11	1,150	0	0	no(M2 and SIP pres)	0
9,093	75.948	0	male	0	13	359	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	null	26	25,038	17,292.6562	15,560.1797	14.5	white	21.597656	43	0.685913	0.593994	4	0	0	no	null	null	no dnr	13	71	4.599609	67	24	36.29688	252.375	null	0.399963	1.299805	141	7.379883	113	32	null	null	2	no(M2 and SIP pres)	2
9,094	69.64795	1	female	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	44	44,632	29,434.5938	39,811.7188	29.333328	white	26.199219	49	0.589966	0.480957	1	0	0	no	0.7	0.85	dnr after sadm	13	178	8.199219	76	20	36.19531	null	2.899902	0.299988	0.699951	132	null	144	8	3,320	null	3	<2 mo. follow-up	3
9,095	18.04199	0	female	0	12	358	MOSF w/Malig	ARF/MOSF	0	null	null	0	32,141	null	null	18	white	29.296875	57	0.600952	0.493958	4	0	0	yes	null	null	no dnr	12	77	11.599609	60	24	35.69531	240	null	null	0.899902	140	7.419922	159	18	null	null	null	null	2.147461
9,096	80.60199	1	female	0	6	295	CHF	COPD/CHF/Cirrhosis	3	8	null	0	4,047	2,704.1426	2,058.89844	12	white	14.898438	33	0.869995	0.783936	1	1	0	no	0.7	0.5	no dnr	6	69	23.5	104	20	36.19531	184	null	0.699951	0.699951	132	7.489258	170	7	1,175	2	null	no(M2 and SIP pres)	1.838867
9,097	66.05597	0	male	0	17	356	Coma	Coma	1	12	$11-$25k	44	19,160	12,187.2031	11,979.5625	10.333328	white	13.898438	19	0.664917	0.606934	1	0	0	yes	0.2	0.1	dnr after sadm	1	56	65.59375	134	10	38.69531	349.0625	null	null	0.799927	142	7.449219	127	19	1,570	null	0	no(M2 and SIP pres)	0
9,098	64.48499	0	female	0	3	356	Lung Cancer	Cancer	2	11	$11-$25k	0	6,830	4,100.5508	3,053.67969	null	white	10.398438	14	0.817993	0.60791	1	1	0	metastatic	0.99	0.99	no dnr	3	64	6.199219	116	8	39.39844	175	3	null	1.699951	129	7.359375	278	59	3,828	null	null	no(M2 and SIP pres)	1.942871
9,099	70.42297	1	male	0	15	17	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	null	0	80,504	56,370.8125	55,285.375	40.666657	white	29.398438	60	0.531982	0.416992	11	1	0	yes	0.5	0.5	dnr after sadm	13	129	24.597656	57	10	37.5	217	null	null	1.199951	136	7.419922	179	22	2,010	null	null	<2 mo. follow-up	2.714844
9,100	68.61597	0	female	0	4	353	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	0	2,758	1,847.376	1,976.73926	3	white	15.298828	19	0.865967	0.778931	1	0	0	yes	null	null	dnr after sadm	1	71	12.599609	110	10	36.19531	135	4.099609	0.599976	0.799927	128	7.489258	142	17	950	0	null	no(M2 and SIP pres)	0.494751